Your session is about to expire
← Back to Search
Spatiomotor Rehabilitation for Blindness & Visual Impairment
Study Summary
This trial will test a new rehabilitation method to help improve the navigational abilities of people who are blind or visually impaired, and study the brain changes that result from the training.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have problems with your brain and nerves that affect your behavior.You have difficulty controlling your arms or legs.You have very poor vision, from not being able to see well to not being able to see at all.Your vision is very poor, ranging from less than 20/500 to no light perception.Your brain size is within the normal range for your height.Your brain size is within the normal range for your weight.You cannot hear and understand instructions.
- Group 1: Blindness history
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly participants being enrolled in this experiment?
"This medical experiment is open to individuals aged 18 and above, up until the age of 80."
How many participants are currently enrolled in this research project?
"Affirmative. The details of this medical trial, first posted on February 15th 2022, are publicly accessible via clinicaltrials.gov and it is currently recruiting participants - 75 individuals from 1 treatment site."
Do I meet the criteria to take part in this scientific research?
"The goal of this clinical trial is to recruit 75 people with amaurosis aged 18-80. Essential eligibility requirements include visual acuity between 20/500 and NLP, physical size within 1 standard deviation of the average for their gender, tolerance towards MRI scans, and more."
Are there any opportunities for patients to participate in this trial at present?
"All the data on clinicaltrials.gov points to this trial being actively open for recruitment, with a launch date of February 15th 2022 and its latest amendment made May 11th 2022."
What goals are this trial hoping to accomplish?
"The primary outcome assessed over a 3-6 month time span will be the maintenance of change in GCC density in the cortical navigation network. Secondary outcomes include transfer of training to untrained spatio-cognitive abilities, measured by score on the Cognitive Test for the Blind (CTB) of McCarron Dial Comprehensive Vocational Evaluation System; change in mobility self-assessment as determined by Kuyk Mobility Function Questionnaire for blindness and profound visual impairment; and maintenance of transfer of training to untrained spatio cognitive abilities, also measured by CTB scores."
Share this study with friends
Copy Link
Messenger